| Log in

Pfizer to sell Thane plant for $27M

23 September, 2015

The Indian arm of drug maker Pfizer Inc has agreed to sell its Thane plant to a little-known firm for around Rs 178 crore ($27.1 million), according to a stock market disclosure.

The plant is being purchased by Vidhi Research and Development LLP, a firm run by Jayeshkumar Kotak.

In July, Pfizer Ltd had said it plans to close the Thane plant from September 16. It also said that there had been no production at the plant since 2013 and that the closure would not impact the supply of any medicine. The plant was commissioned in the 1960s and employs 212 people. It supplied drugs to both domestic and international markets.


Leave Your Comment
Pfizer, Teva Pharma & PE Firms Eye Micro Labs Buyout

Pfizer, Teva Pharma & PE Firms Eye Micro Labs Buyout

Shrija Agrawal 6 years ago
After Ranbaxy Labs and Piramal Healthcare, another billion-dollar-plus deal...
Lyka Labs selling its formulations unit at Tarapur for $6M

Lyka Labs selling its formulations unit at Tarapur for $6M

Jasleen Kaur Batra 3 years ago
Mumbai-based small drug manufacturer Lyka Labs Ltd has signed a deal to sell its...
Pfizer consolidating Indian units, to hold 63% after merging Wyeth

Pfizer consolidating Indian units, to hold 63% after merging Wyeth

Bhawna Gupta 4 years ago
The world’s largest drug maker Pfizer is consolidating two public listed arms...
No Comments

Pfizer to sell Thane plant for $27M

Powered by WordPress.com VIP